Indications and uses
temporarily relieves the symptoms of severe cold and flu including the early onset of flu, runny nose and nasal congestion, sore, hoarse throat, cough, headache and body aches, fatigue, fever and chills.
temporarily relieves the symptoms of severe cold and flu including the early onset of flu, runny nose and nasal congestion, sore, hoarse throat, cough, headache and body aches, fatigue, fever and chills.
Sip while hot • Consume entire drink within 10-15 minutes • If using a microwave, heat the water first and then add the contents of the packet while stirring adults and children 12 years and over dissolve one packet in 8 oz of hot water up to 6 times a day (every 4 hours) or as directed by a licensed health care professional children 6 years to under 12 years dissolve half a packet in 4 oz of warm water up to 6 ti...
Drug Facts
| Active Ingredients
Each packet contains 160 mg of: | Purpose |
|---|---|
| "HPUS" indicates the active ingredients are in the official Homeopathic Pharmacopœia of the United States. | |
| Aconitum Napellus 6X HPUS | Sore throat, cough |
| Anas Barbariae Hepatis et Cordis Extractum 200C HPUS | Early onset flu, including fever, chills and body aches |
| Bryonia 6X HPUS | Headache, fatigue, fever |
| Eupatorium Perfoliatum 6X HPUS | Fever with chills, body aches, headache |
| Euphrasia Officinalis 6X HPUS | Nasal congestion, runny nose, cough |
| Gelsemium Sempervirens 6X HPUS | Hoarse throat, fatigue, fever |
| Kali Iodatum 6X HPUS | Headache, sore throat |
temporarily relieves the symptoms of severe cold and flu including the early onset of flu, runny nose and nasal congestion, sore, hoarse throat, cough, headache and body aches, fatigue, fever and chills.
As with any drug, ask a doctor before use if pregnant or nursing. Consult a physician if:
Keep this and all medications out of the reach of children. In case of accidental overdose, contact a medical professional or a poison control center immediately.
Do not use this product for persistent or chronic cough such as asthma, smoking or emphysema or if cough is accompanied by excessive mucus, unless directed by a licensed health care professional.
A persistent cough may be a sign of a serious condition.
Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult a doctor promptly.
Do not use if packet is torn or damaged.
In case of emergency, contact a medical professional or poison control center immediately. Hyland's may also be contacted for emergency information about our products 24 hours a day, 7 days per week at (800) 624-9659.
Sip while hot • Consume entire drink within 10-15 minutes • If using a microwave, heat the water first and then add the contents of the packet while stirring
| adults and children 12 years and over | dissolve one packet in 8 oz of hot water up to 6 times a day (every 4 hours) or as directed by a licensed health care professional |
| children 6 years to under 12 years | dissolve half a packet in 4 oz of warm water up to 6 times a day (every 4 hours) or as directed by a licensed health care professional |
| children 2 years to under 6 years | consult a doctor |
Citric Acid USP, Fructose, Honey Powder, Lactose N.F., Natural Color, Natural Flavors, Silicon Dioxide (absorbs moisture).
(800) 624-9659
NDC 54973-3156-2
HOMEOPATHIC
SINCE 1903
Hyland's
®
DEFEND ™
SEVERE
COLD + FLU
Natural,Safe & Effective Relief of:
Runny Nose, Nasal Congestion
Body Aches & Headache
Sore Throat
Fatigue
Natural Lemon & Honey Flavor
Dye Free • No Artificial Flavors or Sweeteners
6 PACKETS | (0.56 OZ EACH) NET WT. 3.36 OZ
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACONITUM NAPELLUS ROOT | ACTIVE INGREDIENT | KPD2N7348X | 2 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 2 | |
| CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE | ACTIVE INGREDIENT | RN2HC612GY | 2 | |
| EUPATORIUM PERFOLIATUM FLOWERING TOP | ACTIVE INGREDIENT | 1W0775VX6E | 2 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 2 | |
| POTASSIUM IODIDE | ACTIVE INGREDIENT | 1C4QK22F9J | 2 | |
| ACONITUM NAPELLUS ROOT | ACTIVE MOIETY | KPD2N7348X | 2 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 2 | |
| CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE | ACTIVE MOIETY | RN2HC612GY | 2 | |
| EUPATORIUM PERFOLIATUM FLOWERING TOP | ACTIVE MOIETY | 1W0775VX6E | 2 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 2 | |
| IODIDE ION | ACTIVE MOIETY | 09G4I6V86Q | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| FRUCTOSE | INACTIVE INGREDIENT | 6YSS42VSEV | 2 | |
| GREEN TEA LEAF | INACTIVE INGREDIENT | W2ZU1RY8B0 | 2 | |
| HONEY | INACTIVE INGREDIENT | Y9H1V576FH | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 2 | |
| LEMON | INACTIVE INGREDIENT | 24RS0A988O | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54973-3156 | 54973-3156-1, 54973-3156-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SOLUTION / RECTAL | 0.67 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | POWDER, FOR SOLUTION / ORAL | 2625 mg/5ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 205 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 72 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| FRUCTOSE | FRUCTOSE | 6YSS42VSEV | SUSPENSION, EXTENDED RELEASE / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d43d3150-df98-81b1-e053-2a95a90a168b | 9419c8b7-2cc6-46c8-b4cd-608c1df0cab9 | 2021-12-28 | Warnings | 9419c8b7-2cc6-46c8-b4cd-608c1df0cab9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.